APOA5 T1259C (rs226788) is significantly associated with blood triglyceride levels in renal dysfunction [124], thus suggesting that modulation of APOA5 to regulate blood triglyceride levels might be a key factor contributing to the development of CKD as well as T2D nephropathy. This evidence concerns the gene APOA5 and chronic kidney disease.